UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

PloS one, 2019-08, Vol.14 (8), p.e0220697-e0220697

2019

Volltextzugriff (PDF)

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Scientific reports, 2023-11, Vol.13 (1), p.20039-20039, Article 20039

2023

Volltextzugriff (PDF)

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.307-314

2018

Volltextzugriff (PDF)

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

Frontiers in medicine, 2021-09, Vol.8, p.718896-718896

2021

Volltextzugriff (PDF)

Indications for portal pressure measurement in chronic liver disease

Scandinavian journal of gastroenterology, 2012-09, Vol.47 (8-9), p.887-892

2012

Volltextzugriff (PDF)

A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis

Hepatology communications, 2024-05, Vol.8 (5)

2024

Volltextzugriff (PDF)

Editorial: timing of carvedilol – promoting survivors in cirrhosis

Alimentary pharmacology & therapeutics, 2022-07, Vol.56 (1), p.172-173

2022

Volltextzugriff (PDF)

Postprandial dysfunction in fatty liver disease

Physiological reports, 2023-04, Vol.11 (8), p.e15653-n/a

2023

Volltextzugriff (PDF)

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series

Medicina (Kaunas, Lithuania), 2020-10, Vol.56 (11), p.565

2020

Volltextzugriff (PDF)

Editorial: non‐selective beta blockers—in and out of circulation

Alimentary pharmacology & therapeutics, 2021-03, Vol.53 (5), p.632-633

2021

Volltextzugriff (PDF)

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Cochrane database of systematic reviews, 2018-10, Vol.10 (10), p.CD011510

2018

Volltextzugriff (PDF)

Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study

Journal of hepatology, 2022-07, Vol.77, p.S64-S65

2022

Volltextzugriff (PDF)

Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial

Hepatology (Baltimore, Md.), 2017-02, Vol.65 (2), p.592-603

2017

Volltextzugriff (PDF)

Prognosis of patients with ascites after PleurX insertion: an observational study

Scandinavian journal of gastroenterology, 2018-03, Vol.53 (3), p.340-344

2018

Volltextzugriff (PDF)

Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosis

Cochrane library, 2015-02

2015

Volltextzugriff (PDF)

Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Journal of hepatology, 2023-06, Vol.78, p.S239-S240

2023

Volltextzugriff (PDF)

WED-325 - Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Journal of hepatology, 2023-06, Vol.78, p.S239-S240

2023

Volltextzugriff (PDF)

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

Gut, 2011-09, Vol.60 (9), p.1254-1259

2011

Volltextzugriff (PDF)

Kinetics of the soluble urokinase plasminogen activator receptor

PloS one, 2019-08, Vol.14 (8), p.e0220697

2019

Volltextzugriff (PDF)

Postprandial dysfunction in metabolic associated fatty liver disease (MAFLD)

Journal of hepatology, 2022-07, Vol.77, p.S154

2022

Volltextzugriff (PDF)

Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals

Journal of hepatology, 2022-07, Vol.77, p.S331

2022

Volltextzugriff (PDF)

SAT193 - Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Journal of hepatology, 2020-08, Vol.73, p.S749-S750

2020

Volltextzugriff (PDF)

Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Journal of hepatology, 2020-08, Vol.73, p.S749-S750

2020

Volltextzugriff (PDF)

Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2024-06, Vol.326 (6), p.G736

2024

Volltextzugriff (PDF)

273-OR: Postprandial Dysfunction in Metabolic Associated Fatty Liver Disease (MAFLD)

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(47)
Webseiten
(1)

Sprache

Englisch
(46)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Humans
(26)
Gastroenterology & Hepatology
(20)
Female
(19)
Male
(18)
Middle Aged
(15)
Liver Cirrhosis
(13)
Cirrhosis
(11)
Adult
(8)
Aged
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Liver Cirrhosis - Complications
(7)
Liver Diseases
(7)
Inflammation
(6)
Liver Cirrhosis - Drug Therapy
(6)
Portal Hypertension
(6)
Adrenergic Beta-Antagonists - Therapeutic Use
(5)
Biopsy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study

Indications for portal pressure measurement in chronic liver disease

A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis

Editorial: timing of carvedilol – promoting survivors in cirrhosis

Postprandial dysfunction in fatty liver disease

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series

Editorial: non‐selective beta blockers—in and out of circulation

Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study

Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial

Prognosis of patients with ascites after PleurX insertion: an observational study

Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosis

Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

WED-325 - Atorvastatin reduces inflammation markers TNF-α, CD62L and MMP2 in a randomised trial

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

Kinetics of the soluble urokinase plasminogen activator receptor

Postprandial dysfunction in metabolic associated fatty liver disease (MAFLD)

Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals

SAT193 - Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Tunnelated peritoneal catheter versus large volume paracentesis for refractory ascites in cirrhosis: a randomized controlled trial

Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease

273-OR: Postprandial Dysfunction in Metabolic Associated Fatty Liver Disease (MAFLD)

Suchergebnisse filtern